A Multi-Center, Ascending Dose Trial to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CD-NP Infusions in Patients With Congestive Heart Failure.

Trial Profile

A Multi-Center, Ascending Dose Trial to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CD-NP Infusions in Patients With Congestive Heart Failure.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 May 2009

At a glance

  • Drugs Cenderitide (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 27 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 May 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 19 Oct 2008 Planned end date changed from May 2008 to Nov 2008, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top